These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23421407)

  • 1. Incidence rate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003-2005.
    Nyström HF; Jansson S; Berg G
    Clin Endocrinol (Oxf); 2013 May; 78(5):768-76. PubMed ID: 23421407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hyperthyroidism in Sweden.
    Abraham-Nordling M; Byström K; Törring O; Lantz M; Berg G; Calissendorff J; Nyström HF; Jansson S; Jörneskog G; Karlsson FA; Nyström E; Ohrling H; Orn T; Hallengren B; Wallin G
    Eur J Endocrinol; 2011 Dec; 165(6):899-905. PubMed ID: 21908653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study.
    Carlé A; Pedersen IB; Knudsen N; Perrild H; Ovesen L; Rasmussen LB; Laurberg P
    Eur J Endocrinol; 2011 May; 164(5):801-9. PubMed ID: 21357288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects of hyperthyroidism in areas of different supplies of iodine. Results of a European prospective study].
    Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
    Schweiz Med Wochenschr; 1987 Aug; 117(34):1245-55. PubMed ID: 3672070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.
    Träisk F; Tallstedt L; Abraham-Nordling M; Andersson T; Berg G; Calissendorff J; Hallengren B; Hedner P; Lantz M; Nyström E; Ponjavic V; Taube A; Törring O; Wallin G; Asman P; Lundell G;
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3700-7. PubMed ID: 19723755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Natural History of Subclinical Hyperthyroidism in Graves' Disease: The Rule of Thirds.
    Zhyzhneuskaya S; Addison C; Tsatlidis V; Weaver JU; Razvi S
    Thyroid; 2016 Jun; 26(6):765-9. PubMed ID: 27090092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immigration and the incidence of Graves' thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma.
    Lantz M; Abraham-Nordling M; Svensson J; Wallin G; Hallengren B
    Eur J Endocrinol; 2009 Feb; 160(2):201-6. PubMed ID: 19004985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hyperthyroidism: aetiology, clinical features and treatment outcome.
    Iglesias P; Dévora O; García J; Tajada P; García-Arévalo C; Díez JJ
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):551-7. PubMed ID: 19681915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of hyperthyroidism in Stockholm, Sweden, 2003-2005.
    Abraham-Nordling M; Törring O; Lantz M; Hallengren B; Ohrling H; Lundell G; Calissendorff J; Jörneskog G; Wallin G
    Eur J Endocrinol; 2008 Jun; 158(6):823-7. PubMed ID: 18505903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.
    Sieminska L; Niedziolka D; Pillich A; Kos-Kudla B; Marek B; Nowak M; Borgiel-Marek H
    J Endocrinol Invest; 2008 Sep; 31(9):745-9. PubMed ID: 18997483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased TRAb and/or low anti-TPO titers at diagnosis of graves' disease are associated with an increased risk of developing ophthalmopathy after onset.
    Lantz M; Planck T; Asman P; Hallengren B
    Exp Clin Endocrinol Diabetes; 2014 Feb; 122(2):113-7. PubMed ID: 24554511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
    Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
    Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperthyroidism in a hospital environment: 5-year evaluation].
    Vilar H; Nobre EL; Jorge Z; Lopes C; André S; Salgado L; Macedo A; De Castro JJ
    Acta Med Port; 2006; 19(4):295-300. PubMed ID: 17328846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the levels of anti-thyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves' disease.
    Alnaqdy A; Al-Maskari M
    Med Princ Pract; 2005; 14(4):209-12. PubMed ID: 15961927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease.
    Stein JD; Childers D; Gupta S; Talwar N; Nan B; Lee BJ; Smith TJ; Douglas R
    JAMA Ophthalmol; 2015 Mar; 133(3):290-6. PubMed ID: 25502604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays.
    Zöphel K; Roggenbuck D; von Landenberg P; Wunderlich G; Grüning T; Kotzerke J; Lackner KJ; Rees Smith B
    Horm Metab Res; 2010 Jan; 42(1):65-9. PubMed ID: 19830651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic criteria of Graves' disease and especially the thyrotropin receptor antibody; our own experience.
    Paunkovic N; Paunkovic J
    Hell J Nucl Med; 2007; 10(2):89-94. PubMed ID: 17684583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSH receptor antibodies for confirming the diagnosis and prediction of remission duration, in newly diagnosed Graves' disease patients.
    Aleksić A; Aleksić Z; Stojanović M
    Hell J Nucl Med; 2009; 12(2):146-50. PubMed ID: 19675869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical and laboratory findings in Graves' multinodular type disease].
    Grammaticos P; Vasiliou O; Papanastasiou E; Gerasimou G; Balaris V; Alexandris R; Liaros G; Dedousi E
    Hell J Nucl Med; 2006; 9(1):53-9. PubMed ID: 16617399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence and functional role of antithyroid antibodies in hyperthyroidism].
    Tagliabue L; Bestetti A; Dileo C; Posterli R; Cereda A; Tarolo GL
    Radiol Med; 1998 Mar; 95(3):188-92. PubMed ID: 9638164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.